Snot a Problem
Dead of winter isn't allergy prime time, but the arrival of cheap, over-the-counter Claritin will still cheer millions. The price of the drug is expected to fall by 75 percent as its patent expires and drug makers compete (!) to sell the stuff. The first cheapie pills will go on sale this week. Long time coming.
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post comments
Claritin doesn't do a thing for me; I use another drug, one that the insurance companies are threatening to stop covering (paying for) once Claritin is OTC.
Previously a prescription drug I used went OTC; as a result I am now paying $30 a month instead of the $4 I paid for a month's supply when it was prescription only and therefore covered by my insurance.
How come no one has commented on the curious coincidence that, now that the patent has expired and the patent owner can't gouge HMOs anymore, Claritin is suddenly no longer a dangerous enough medication to warrant a prescription?
And more interestingly, most clinical trials of Claritin show it to be no more effective than a sugar pill in almost all cases.